arcadia

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE627.15-10.4 (-1.63 %)
PREV CLOSE ( ) 637.55
OPEN PRICE ( ) 639.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 627.15 (446)
VOLUME 103066
TODAY'S LOW / HIGH ( )625.30 644.15
52 WK LOW / HIGH ( )508.1 663
NSE627.40-10.05 (-1.58 %)
PREV CLOSE( ) 637.45
OPEN PRICE ( ) 640.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 627.40 (568)
VOLUME 2348371
TODAY'S LOW / HIGH( ) 625.10 644.00
52 WK LOW / HIGH ( )507.2 663.4
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX
NEWS
12Jul Power Grid, Uttam Sugar and Essel Prop
Power Grid Corporation of India (PGCIL) has commenced commercial operati..
12Jul Cipla’s arm inks agreement to acquire
Cipla’s wholly owned subsidiary - Cipla Medpro South Africa has signed a..
12Jul Cipla gains with arm inking agreement
Cipla scrip is currently trading at Rs. 627.20, up by 2.50 points or 0.4..
12Jul Cipla informs about acquisition
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
09Jul Cipla informs about board meeting
Cipla has informed that a meeting of the Board of Directors of the Compa..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit2248.114685.2
Gross Profit 2716.7 19114
Operating Profit 4862.325304.3
Net Sales 27253.4114448.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7179.55 (2.08%)
M.Cap ( in Cr)15256.04
Piramal Enterprises (BSE)
 2558.45 (1.31%)
M.Cap ( in Cr)46205.04
Astrazeneca Pharma I (BSE)
 1423.70 (1.71%)
M.Cap ( in Cr)3559.25
Pfizer (BSE)
 2571.10 (0.79%)
M.Cap ( in Cr)11762.20
Zim Laboratories (BSE)
 350.00 (4.48%)
M.Cap ( in Cr)282.09
Shareholding Pattern
PROMOTERS 37.21%
NON-INSTITUTION 24.69%
MUTUAL FUNDS/UTI 10.07%
FI/BANKS/INSURANCE 3.81%
FII 0.31%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM